INCREASED PROLIFERATION OF A HUMAN BREAST-CARCINOMA CELL-LINE BY RECOMBINANT INTERLEUKIN-2

Citation
M. Katano et al., INCREASED PROLIFERATION OF A HUMAN BREAST-CARCINOMA CELL-LINE BY RECOMBINANT INTERLEUKIN-2, Cancer immunology and immunotherapy, 39(3), 1994, pp. 161-166
Citations number
25
Categorie Soggetti
Immunology,Oncology
ISSN journal
03407004
Volume
39
Issue
3
Year of publication
1994
Pages
161 - 166
Database
ISI
SICI code
0340-7004(1994)39:3<161:IPOAHB>2.0.ZU;2-#
Abstract
Two adenocarcinoma cell lines, Breast M25-SF and Breast M, were establ ished from tumor tissue resected surgically from a patient with breast cancer. One, Breast M25-SF, expresses interleukin-2 receptor (IL-2R) on the cell surface and the other, Breast M, does not. The effects of recombinant interleukin-2 (rIL-2) on the proliferation of these cell l ines were investigated. The growth of Breast M25-SF was significantly promoted by rIL-2 ranging from 1.25 U/ml to 640 U/ml. Anti-CD25 (Tac) antibody significantly blocked the growth enhancement of Breast M25-SF by rIL-2. Breast M, however, did not respond to rIL-2. To confirm mor e directly the promotion of Breast M25-SF growth by rIL-2, cloning of IL-2 responders from parent Breast M25-SF cells was carried out by lim iting dilution without feeder cells in 96-well microplates. No colony formation was found in 24 wells without rIL-2. Eleven, 13 and 6 clones were established from groups of 24 wells containing rIL-2 at 200, 20 and 2 U/ml respectively. All of the clones expressed IL-2R and respond to rIL-2. By using a sensitive polymerase chain reaction technique, w e demonstrated that Breast M25-SF but not Breast M expressed IL-2 mRNA , and IL-2 secretion from Breast M25-SF but not Breast M was also conf irmed by radioimmunoassay. These findings suggest a role for IL-2 in a utocrine support of Breast M25-SF growth. IL-2 may play an important r ole in the growth control of breast carcinoma cells.